MDS - Myeloplastic Syndromes - 2023 Best of Hematology Conference

Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia - 2023 Best of Hematology ConferenceПодробнее

Updates in the Myelodysplastic Syndromes: 2023 Best of HematologyПодробнее

MDS 2023 highlights: classification and risk stratification systems & progression from CH to MDSПодробнее

Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathologyПодробнее

Day 2 Panel - 2023 Best of Hematology ConferenceПодробнее

Chronic Myeloid Leukemia -2023 Best of Hematology ConferenceПодробнее

The clinical activity of imetelstat in patients with MDS and anemiaПодробнее

MDS - AML - 2020 Spring Virtual Conference: When MDS becomes AML - for High-Risk MDS PatientsПодробнее

MDS new therapy optionsПодробнее

2021 West Oncology | Hematological Malignancies | Updates in Myelodysplastic SyndromesПодробнее

Understanding Myelodysplastic syndromesПодробнее

Myelodysplastic Syndrome (MDS) - a precursor to Acute Myeloid Leukemia (AML) ?! - Hematology SeriesПодробнее

Updates in CLL - 2023 Best of Hematology ConferenceПодробнее

Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting*Подробнее

Treating myelodysplastic syndromesПодробнее

Prognostic value of the updated ICC and WHO classifications for MDSПодробнее

EHA and ASCO 2023 highlights: promising treatments in AML, MDS, and ALLПодробнее

Emerging targeted treatments for MDSПодробнее